Compounds > atranorin
Page last updated: 2024-08-24

atranorin and Cell Transformation, Neoplastic

atranorin has been researched along with Cell Transformation, Neoplastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hur, JS; Kim, H; Kim, KK; Lee, JH; Lee, KH; Nguyen, TT; Park, SY; Seo, YW; Yang, Y; Zhou, R1
Jeon, YJ; Kim, JH; Kim, S; Suh, SS; Youn, UJ1

Other Studies

2 other study(ies) available for atranorin and Cell Transformation, Neoplastic

ArticleYear
The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis.
    Scientific reports, 2017, 08-15, Volume: 7, Issue:1

    Topics: Antineoplastic Agents; beta Catenin; Biological Products; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Hydroxybenzoates; Lichens; Lung Neoplasms; Proto-Oncogene Proteins c-jun; rho GTP-Binding Proteins; Secondary Metabolism; Signal Transduction; Transcription Factor AP-1

2017
The Comprehensive Roles of ATRANORIN, A Secondary Metabolite from the Antarctic Lichen
    Molecules (Basel, Switzerland), 2019, Apr-10, Volume: 24, Issue:7

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Hydroxybenzoates; Lichens; Liver Neoplasms

2019